First Time Loading...

Beijing Strong Biotechnologies Inc
SZSE:300406

Watchlist Manager
Beijing Strong Biotechnologies Inc Logo
Beijing Strong Biotechnologies Inc
SZSE:300406
Watchlist
Price: 17.67 CNY 0.23% Market Closed
Updated: May 16, 2024

Beijing Strong Biotechnologies Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Strong Biotechnologies Inc
Cost of Revenue Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Strong Biotechnologies Inc
SZSE:300406
Cost of Revenue
-¥452.6m
CAGR 3-Years
-4%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cost of Revenue
-¥2.7B
CAGR 3-Years
-77%
CAGR 5-Years
-70%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cost of Revenue
-¥1.1B
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cost of Revenue
-¥992.7m
CAGR 3-Years
-28%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cost of Revenue
-¥39.6B
CAGR 3-Years
-58%
CAGR 5-Years
-63%
CAGR 10-Years
-63%
Imeik Technology Development Co Ltd
SZSE:300896
Cost of Revenue
-¥99.9m
CAGR 3-Years
-34%
CAGR 5-Years
-27%
CAGR 10-Years
N/A

See Also

What is Beijing Strong Biotechnologies Inc's Cost of Revenue?
Cost of Revenue
-452.6m CNY

Based on the financial report for Mar 31, 2024, Beijing Strong Biotechnologies Inc's Cost of Revenue amounts to -452.6m CNY.

What is Beijing Strong Biotechnologies Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-12%

Over the last year, the Cost of Revenue growth was -18%. The average annual Cost of Revenue growth rates for Beijing Strong Biotechnologies Inc have been -4% over the past three years , -12% over the past five years .